Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway

Oncology Reports

Volumn 33, Issue 6, 2015, Pages 3085-3092

  Bai, Xue ^a   Ma, Yaxin ^b   Zhang, Guobin ^a  

^a No 202 Hospital of PLA   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Apoptosis; Butein; Cervical cancer; Reactive oxygen species

Indexed keywords

BUTEIN; CASPASE 3; CASPASE 8; CASPASE 9; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; CHALCONE DERIVATIVE; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL MIGRATION; CELL VIABILITY; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; HELA CELL LINE; HUMAN; IN VITRO STUDY; INTRACELLULAR SIGNALING; MOUSE MODEL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR XENOGRAFT; UTERINE CERVIX CANCER; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MOUSE; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CHALCONES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICE; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; UTERINE CERVICAL NEOPLASMS;

EID: 84928910840     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3922     Document Type: Article

References (41)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Martin-Hirsch PL and Wood NJ: Cervical cancer. BMJ Clin Evid: Jul 27, 2011. pii: 0818.
3. Duenas-Gonzalez A, Serrano-Olvera A, Cetina L and Coronel J: New molecular targets against cervical cancer. Int J Womens Health 6: 1023-1031, 2014.
4. de Freitas AC, Gomes Leitão Mda C and Coimbra EC: Prospects of molecularly-targeted therapies for cervical cancer treatment. Curr Drug Targets 16: 77-91, 2015.
5. Jakubowicz J, Blecharz P, Skotnicki P, Reinfuss M, Walasek T and Luczynska E: Toxicity of concurrent chemoradiotherapy for locally advanced cervical cancer. Eur J Gynaecol Oncol 35: 393-399, 2014.
6. Bazaeva IIa, Gorbunova VA, Kravets OA, Khokhlova SV, Limareva SV, Panov VO, Strel'tsova ON and Tarachkova EV: Chemoradiotherapy for locally advanced cervical cancer. Vopr Onkol 60: 280-287, 2014 (In Russian).
7. Butler MS: The role of natural product chemistry in drug discovery. J Nat Prod 67: 2141-2153, 2004.
8. Paterson I and Anderson EA: Chemistry. The renaissance of natural products as drug candidates. Science 310: 451-453, 2005.
9. Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N and Moore MA: Cancer prevention by natural compounds. Drug Metab Pharmacokinet 19: 245-263, 2004.
10. Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E and Capaccioli S: Natural compounds for cancer treatment and prevention. Pharmacol Res 59: 365-378, 2009.
11. Huang WY, Cai YZ and Zhang Y: Natural phenolic compounds from medicinal herbs and dietary plants: Potential use for cancer prevention. Nutr Cancer 62: 1-20, 2010.
12. McCarty MF: Current prospects for controlling cancer growth with non-cytotoxic agents - nutrients, phytochemicals, herbal extracts, and available drugs. Med Hypotheses 56: 137-154, 2001.
13. Lazzeroni M, Gandini S, Puntoni M, Bonanni B, Gennari A and DeCensi A: The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it. Breast 20 (Suppl 3): S36-S41, 2011.
14. Moon DO, Choi YH, Moon SK, Kim WJ and Kim GY: Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells. Toxicol In Vitro 24: 1927-1934, 2010.
15. Kojima R, Kawachi M and Ito M: Butein suppresses ICAM-1 expression through the inhibition of IκBα and c-Jun phosphorylation in TNF-α- and PMA-treated HUVECs. Int Immunopharmacol 24: 267-275, 2015.
16. Rasheed Z, Akhtar N, Khan A, Khan KA and Haqqi TM: Butrin, isobutrin, and butein from medicinal plant Butea monosperma selectively inhibit nuclear factor-kappaB in activated human mast cells: Suppression of tumor necrosis factor-alpha, interleukin (IL)-6, and IL-8. J Pharmacol Exp Ther 333: 354-363, 2010.
17. Lee SH, Seo GS and Sohn DH: Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by butein in RAW 264.7 cells. Biochem Biophys Res Commun 323: 125-132, 2004.
18. Chan SC, Chang YS, Wang JP, Chen SC and Kuo SC: Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Med 64: 153-158, 1998.
19. Yit CC and Das NP: Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Lett 82: 65-72, 1994.
20. Li Y, Ma C, Qian M, Wen Z, Jing H and Qian D: Butein induces cell apoptosis and inhibition of cyclooxygenase-2 expression in A549 lung cancer cells. Mol Med Rep 9: 763-767, 2014.
21. Cui Z, Song E, Hu DN, Chen M, Rosen R and McCormick SA: Butein induces apoptosis in human uveal melanoma cells through mitochondrial apoptosis pathway. Curr Eye Res 37: 730-739, 2012.
22. Khan N, Adhami VM, Afaq F and Mukhtar H: Butein induces apoptosis and inhibits prostate tumor growth in vitro and in vivo. Antioxid Redox Signal 16: 1195-1204, 2012.
23. Kim NY, Pae HO, Oh GS, Kang TH, Kim YC, Rhew HY and Chung HT: Butein, a plant polyphenol, induces apoptosis concomitant with increased caspase-3 activity, decreased Bcl-2 expression and increased Bax expression in HL-60 cells. Pharmacol Toxicol 88: 261-266, 2001.
24. Wang Y, Chan FL, Chen S and Leung LK: The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing aromatase. Life Sci 77: 39-51, 2005.
25. Jang HS, Kook SH, Son YO, Kim JG, Jeon YM, Jang YS, Choi KC, Kim J, Han SK, Lee KY, et al: Flavonoids purified from Rhus verniciflua Stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells. Biochim Biophys Acta 1726: 309-316, 2005.
26. Rajendran P, Ong TH, Chen L, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, et al: Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo. Clin Cancer Res 17: 1425-1439, 2011.
27. Chen YH, Yeh CW, Lo HC, Su SL, Hseu YC and Hsu LS: Generation of reactive oxygen species mediates butein-induced apoptosis in neuroblastoma cells. Oncol Rep 27: 1233-1237, 2012.
28. Yadav VR, Prasad S, Sung B and Aggarwal BB: The role of chalcones in suppression of NF-κB-mediated inflammation and cancer. Int Immunopharmacol 11: 295-309, 2011.
29. Kang DG, Lee AS, Mun YJ, Woo WH, Kim YC, Sohn EJ, Moon MK and Lee HS: Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol Pharm Bull 27: 366-370, 2004.
30. Lee SH, Choi WC, Kim KS, Park JW, Lee SH and Yoon SW: Shrinkage of gastric cancer in an elderly patient who received Rhus verniciflua Stokes extract. J Altern Complement Med 16: 497-500, 2010.
31. Hamzeloo-Moghadam M, Aghaei M, Fallahian F, Jafari SM, Dolati M, Abdolmohammadi MH, Hajiahmadi S and Esmaeili S: Britannin, a sesquiterpene lactone, inhibits proliferation and induces apoptosis through the mitochondrial signaling pathway in human breast cancer cells. Tumour Biol 36, 1191-1198, 2015.
32. 2/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation. Cancer Lett 288: 204-213, 2010.
33. Opletalova V, Jahodar L, Jun D and Opletal L: Chalcones (1,3-diarylpropen-1-ones) and their analogs as potential therapeutic agents in cardiovascular system diseases. Ceska Slov Farm 52: 12-19, 2003.
34. Weerasinghe P, Hallock S, Tang SC and Liepins A: Role of Bcl-2 family proteins and caspase-3 in sanguinarine-induced bimodal cell death. Cell Biol Toxicol 17: 371-381, 2001.
35. Cory S and Adams JM: The Bcl2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656, 2002.
36. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M and Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84, 2007.
37. Ali-Seyed M, Bhuvaneswari R, Soo KC and Olivo M: Photolon™ - Photosensitization induces apoptosis via ROS-mediated crosstalk between mitochondria and lysosomes. Int J Oncol 39: 821-831, 2011.
38. Yang LH, Ho YJ, Lin JF, Yeh CW, Kao SH and Hsu LS: Butein inhibits the proliferation of breast cancer cells through generation of reactive oxygen species and modulation of ERK and p38 activities. Mol Med Rep 6: 1126-1132, 2012.
39. Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30: 193-204, 2004.
40. Chen YL, Law PY and Loh HH: Inhibition of PI3K/Akt signaling: An emerging paradigm for targeted cancer therapy. Curr Med Chem Anticancer Agents 5: 575-589, 2005.
41. Liu SC, Chen C, Chung CH, Wang PC, Wu NL, Cheng JK, Lai YW, Sun HL, Peng CY, Tang CH, et al: Inhibitory effects of butein on cancer metastasis and bioenergetic modulation. J Agric Food Chem 62: 9109-9117, 2014.